You are here

OpenMarket: July 2020

  • NEPA Reform Gives More Power to the People, Less to Environmental Lawyers

    July 31, 2020
    The Trump administration’s recent changes to the National Environmental Policy Act would reduce the years of red tape and litigation that frequently blocks job-creating energy projects such as new oil or natural gas pipelines. They would also give a greater voice to the local communities that are positively impacted by such projects.
  • 2020 Second Quarter GDP Decline Is Worst in U.S. History—But Not 32.9 Percent

    July 31, 2020
    The good news is that the second quarter’s GDP numbers aren’t nearly as scary as the more dramatic headlines are saying. The economy has not shrunk by a third. The bad news is that yes, we really have just experienced the worst crash in U.S. history. And it’s not over yet. This post gives some context, and some ideas for how to aid the recovery for both the virus and the economy.
  • A Fond Farewell to a Dear Friend

    July 30, 2020
    James Gattuso (December 1, 1957 – July 23, 2020) has left behind a profound legacy of devotion to family and commitment to liberty. Requiescat in pace
  • R.I.P. Herman Cain (1945-2020)

    July 30, 2020
    Herman Cain was an American original and everything good and bad about politics in one package. A self-made man of ambition and drive who learned how to play game of business and rose to the top level of that world, then set his sights on politics. He was less successful in the latter field due to personal flaws and some skeletons in his closet, but no one can say he didn’t give it his all.
  • Observations from the Tech Antitrust Hearing

    July 30, 2020
    This post collects some observations from yesterday’s lengthy House Judiciary Committee Subcommittee on Antitrust, Commercial, and Administrative Law hearings with the chief executives of Amazon, Apple, Facebook, and Google. In short, committee members addressed a lot of things they shouldn’t have, and did not address some things they perhaps should have.
  • Cheers to Department of Labor for Protecting Retiree Investments

    July 29, 2020
    At the end of last month the Department of Labor published a new notice of proposed rulemaking on the investment choices that private pension fund managers are allowed to make on behalf of their beneficiaries. The most proposed rule would clarify when it is possible to use environmental, social, and governance considerations when investing on behalf of pension fund beneficiaries.
  • Tech Antitrust Hearing as Political Theater

    July 29, 2020
    Large, innovative tech companies have been invaluable during the COVID-19 crisis, helping to ease the burden of millions of Americans and businesses under quarantine. But that won’t stop the House Antitrust Subcommittee from dragging the CEOs of Apple, Amazon, Facebook, and Google before it today. The investigation will have a difficult time meeting the U.S. standard for antitrust: consumer harm.
  • The Socialist Temptation: Socialism and American Values

    July 28, 2020
    The way to reach people is by making sure a policy accorded with their values. In his new book, The Socialist Temptation, Iain Murray argues that the recent rise in popularity of socialism has occurred because socialism talks a very good game when it comes to values. The trouble is that it actually undermines those values.
  • If You Can’t Convince Them, Confuse Them: California Political Establishment Doubles Down on AB5

    July 27, 2020
    Progressives are fond of saying that authority never gives up power easily. California Attorney General Xavier Becerra is demonstrating that by rewriting the ballot language for Proposition 22, which covers rideshare drivers, in order to frame the issue in the most negative way he can.
  • Trump’s Drug Price Control Orders Are Bound to Backfire

    July 27, 2020
    At a White House gathering last Friday, President Trump announced four new executive orders intended to restrict the ways pharmaceutical companies set the price of prescription drugs. Those new rules are likely to backfire. They may produce modestly lower prices for some patients in the short term, but everyone will bear the burden of higher prices and fewer treatment options in the long run.


Subscribe to OpenMarket: July 2020